CDKN2A and T-cell acute lymphoblastic leukemia: Mutations in cell cycle regulators, such as deletions of CDKN2A/B gene (frequency: 5–20% in B-cell precursor and 60–80% in T-cell ALL), have a negative impact in the function of tumour suppressor genes such as TP53 and RB1 [28].